The
following manuscripts are presented as online first for
peer-review, starting from March 2, 2023.
All
comments are welcome:
editor@sciencepub.net
or contact with
author(s) directly.
You can use the message in end of the article abstract to
cite it.
To get Microsoft Documents: After you open the "Full Text" for each
article, change the last 3 characters of the web address from .pdf
to .doc (or .docx)
When you submit manuscript(s),
please mention that it is submitted to the Cancer Biology.
Marsland Press, 310 W 18th
Street, New York, NY 10011, USA.
718-404-5362, 347-321-7172
http://www.cancerbio.net
CONTENTS
No.
|
Titles /
Authors /Abstracts
|
Full Text
|
No.
|
1
|
PREVALENCE OF
HEPATITIS B VIRUS COINFECTION AMONGST HIV-INFECTED PATIENTS IN
CAPITOL HILL HOSPITAL, WARRI, DELTA STATE, NIGERIA
Okonko IO, Asagba
OH, Okonko BJ, Baeka GB
1Virus
& Genomics Research Unit, Department of Microbiology, University
of Port Harcourt, Port Harcourt, Nigeria
2Virology
& Immunology Research Unit, Department of Applied Microbiology,
Ebonyi State University, Abakaliki, Nigeria.
E-mail:
iheanyi.okonko@uniport.edu.ng;
Tel: +2347069697309
ABSTRACT:
Hepatitis B virus (HBV) is the most prevalent aetiology of viral
inflammation of the human liver. This study was conducted to
determine the HIV/HBV coinfection rates among HIV patients in
Warri, Nigeria. A total of 100 patients attending Capitol Hill
hospital in Warri, were recruited for the study and hepatitis B
surface antigen (HBsAg) was determined using Enzyme-Linked
Immunosorbent Assay (ELISA) technique. The age range of the 100
HIV-positive individuals who participated in the study ranges
from 5 to 75 years with an average age of 35.7 years. Thirty-two
per cent (32.0%) of the entire population was in the less than
30 years age range. The majority of the population were females
(55.0%), singles (56.0%), with primary education (34.0%),
students (22.0%) and civil servants (21.0%). Results of the
ELISA showed that HIV/HBV coinfection was 1.0%. The results
showed that HIV/HBV coinfection occurred only among the female
(1.8%), age bracket 31-40 years (3.8%), married (2.3%), those
with tertiary education (2.3%) and traders (4.2%). Thus, this
study confirms a low HIV/HBV coinfection in HIV patients in
Capitol Hill hospital, Warri, Delta State, Nigeria. The observed
drop in HIV/HBV coinfection in this study may be due to a steady
increase in HBV vaccination in the nooks and crannies of the
nation. This study reveals that there is a persistent decline in
the prevalence of HBV in HIV-infected persons. The epidemiology
of HIV/HBV co-infection in Nigeria requires rigorous
surveillance since, despite the overall drop in HBV prevalence,
it remains endemic among HIV-positive people.
[Okonko
IO, Asagba OH, Okonko BJ, Baeka GB. (2023). Prevalence of
Hepatitis B Virus Coinfection Amongst HIV-Infected Patients in
Capitol Hill Hospital, Warri, Delta State, Nigeria.
Cancer Biology 2023;13(1):1-12]. ISSN: 2150-1041 (print); ISSN:
2150-105X (online).
http://www.cancerbio.net
01.doi:10.7537/marscbj130123.01.
Keywords:
HBV, HIV, Coinfection, Nigeria |
Full Text |
1
|
2
|
HIV and
Helicobacter pylori Co-infections among Patients visiting
two selected medical facilities in Port Harcourt, Rivers State,
Nigeria
Okonko IO1*
and Barine, BM2
1Virus
Research Unit, Department of Microbiology, University of Port
Harcourt, Port Harcourt, Nigeria.
2Department
of Microbiology, Faculty of Science, Ebonyi State University,
Abakaliki, Ebonyi State, Nigeria.
*Corresponding
author’s:
E-mail: Iheanyi.okonko@uniport.edu.ng;
Tel.: +2348035380891
Abstract:
The co-infection of HIV and
Helicobacter pylori amongst patients visiting selected
medical facilities in Port Harcourt, Rivers State Nigeria was
investigated. One hundred patients were recruited from selected
hospitals in the city. HIV (Determine) and H. pylori
(ANTI-HP Rapid) rapid test kits were used to assay for
antibodies against the virus and bacterium in the sera of
participants respectively. Other demographics such as age, sex
and marital status was obtained using questionnaires. The result
outcomes showed a 2.0% prevalence of HIV and H. pylori
coinfection specifically in those within age bracket of 17-19
years. No co-infection was observed among children and
adolescent signifying that significant difference (p<0.05)
existed in patients with both infections. Similarly, no
significant difference (p>0.05) was noted in the co-infection
rates reported for males (2.4%) and females (1.7%). Conversely,
no marital status-specific difference (p>0.05) was noted, though
HIV and H. pylori coinfection was only detected in
singles. In conclusion, the study further confirms the presence
of HIV and Helicobacter pylori coinfection among patients
in Port Harcourt, Rivers State, Nigeria. This highlights the
necessity for routine screening of blood for HIV and H.
pylori coinfection to minimize their transmission among the
general population. The need for intensive health education to
enlighten the public on the risk factors associated with both
infections and possible control measures. Further studies of
larger numbers of HIV-1 patients with and without H. pylori
co-infection for a prolonged period of time are needed in order
to define the role of H. pylori co-infection and
eradication in immune reconstitution of HAART-treated HIV-1-
infected patients
[Okonko
IO and Barine, BM.
HIV and Helicobacter pylori Coinfections among
Patients in Port Harcourt, Rivers State, Nigeria.
Cancer Biology
2023;13(1):13-17]. ISSN: 2150-1041 (print); ISSN: 2150-105X
(online).
http://www.cancerbio.net
02.doi:10.7537/marscbj130123.02.
Keywords:
Prevalence, antibodies, Helicobacter pylori, Coinfection |
Full Text |
2
|
3
|
|
Full Text |
3
|
4
|
|
Full Text |
4
|
5
|
|
Full Text |
5
|
6
|
|
Full Text |
6
|
7
|
|
Full Text |
7
|
8
|
|
Full Text |
8
|
9
|
|
Full Text |
9
|
10
|
|
Full Text |
10
|
11
|
|
Full Text |
11
|
12
|
|
Full Text |
12
|
13
|
|
Full Text |
13
|
14
|
|
Full Text |
14
|
15
|
|
Full Text |
15
|
16
|
|
Full Text |
16
|
17
|
|
Full Text |
17
|
18
|
|
Full Text |
18
|
19
|
|
Full Text |
19
|
20
|
|
Full Text |
20
|
21
|
|
Full Text |
21
|
22
|
|
Full Text |
22
|
23 |
|
Full Text |
23 |
24 |
|
Full Text |
24 |
25 |
|
Full Text |
25 |
26 |
|
Full Text |
26 |
27 |
|
Full Text |
27 |
28 |
|
Full Text |
28 |
29 |
|
Full Text |
29 |
30 |
|
Full Text |
30 |
31 |
|
Full Text |
31 |
32 |
|
Full Text |
32 |
33 |
|
Full Text |
33 |
34 |
|
Full Text |
34 |
35 |
|
Full Text |
35 |
36 |
|
Full Text |
36 |
37 |
|
Full Text |
37 |
38 |
|
Full Text |
38 |
39 |
|
Full Text |
39 |
40 |
|
Full Text |
40 |
41 |
|
Full Text |
41 |
42 |
|
Full Text |
42 |
43 |
|
Full Text |
43 |
44 |
|
Full Text |
44 |
45 |
|
Full Text |
45 |
46 |
|
Full Text |
46 |
47 |
|
Full Text |
47 |
48 |
|
Full Text |
48 |
49 |
|
Full Text |
49 |
50 |
|
Full Text |
50 |
The manuscripts in this
issue were presented as online first for peer-review starting
from
March 2, 2023.
All comments are
welcome:
editor@sciencepub.net
For
back issues of the Researcher,
click here.
Emails:
editor@sciencepub.net
|